Position in JAZZ
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$233,281,129
+$45,723,112 QoQ
Shares Held
968,092
-2.4% QoQ
Ownership
1.49%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#18
of 640 holders
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Swedbank AB holds $1,373,398,390 across 23 Biotechnology names. JAZZ ranks #2 (17.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
10,726,608 | $601,440,910 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
968,092 | $233,281,129 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
282,444 | $140,298,407 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
189,848 | $118,377,821 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,314,787 | $75,232,112 | |
| 6 | EXEL |
Exelixis, Inc.
|
841,778 | $45,801,140 | |
| 7 | INCY |
Incyte Corp
|
371,387 | $42,100,430 | |
| 8 | 775,032 | $24,359,255 |
All Filings in JAZZ
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $233,281,129 | 968,092 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $187,558,017 | 992,108 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $187,505,580 | 1,102,974 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $141,565,325 | 1,074,092 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $113,982,643 | 1,074,092 | Shares | Defined | 2025-07-10 | |
| 2024-12-31 | $123,387,925 | 1,001,932 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $111,625,244 | 1,001,932 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $106,936,202 | 1,001,932 | Shares | Defined | 2024-07-11 | |
| 2023-12-31 | $126,718,044 | 1,030,228 | Shares | Defined | 2024-12-06 | |
| 2023-09-30 | $145,495,349 | 1,124,037 | Shares | Defined | 2024-12-06 | |
| 2023-06-30 | $135,310,031 | 1,091,474 | Shares | Defined | 2024-12-06 | |
| 2023-03-31 | $139,017,304 | 950,026 | Shares | Defined | 2024-12-06 | |
| 2022-12-31 | $28,930,377 | 181,598 | Shares | Defined | 2024-12-06 | |
| 2022-09-30 | $23,861,975 | 179,023 | Shares | Defined | 2024-12-06 | |
| 2022-06-30 | $27,462,596 | 176,031 | Shares | Defined | 2024-12-06 | |
| 2022-03-31 | $26,634,047 | 171,093 | Shares | Defined | 2024-12-06 | |
| 2021-12-31 | $20,891,179 | 163,981 | Shares | Defined | 2024-12-06 | |
| 2021-09-30 | $20,261,587 | 155,607 | Shares | Defined | 2024-12-06 | |
| 2021-06-30 | $27,642,027 | 155,607 | Shares | Defined | 2024-12-06 | |
| 2021-03-31 | $23,562,932 | 143,353 | Shares | Defined | 2024-12-06 | |
| No filing history on record for this holder in this stock. | ||||||